A let-7 microRNA-binding site polymorphism in KRAS predicts improved outcome in metastatic colorectal cancer (mCRC) patients treated with salvage cetuximab/panitumumab monotherapy

Por Saridaki, Zenia, Weidhaas, Joanne B., Lenz, Heinz-Josef, Laurent-Puig, Pierre, Jacobs, Bart, De Schutter, Jef, De Roock, Wendy, Salzman, David W., Zhang, Wu, Yang, Dongyun, Pilati, Camilla, Bouché, Olivier, Piessevaux, Hubert, Tejpar, Sabine
Publicado em 2014

Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes

Por Pentheroudakis, George, Kotoula, Vassiliki, De Roock, Wendy, Kouvatseas, George, Papakostas, Pavlos, Makatsoris, Thomas, Papamichael, Demetris, Xanthakis, Ioannis, Sgouros, Joseph, Televantou, Despina, Kafiri, Georgia, Tsamandas, Athanassios C, Razis, Evangelia, Galani, Eleni, Bafaloukos, Dimitrios, Efstratiou, Ioannis, Bompolaki, Iliada, Pectasides, Dimitrios, Pavlidis, Nicholas, Tejpar, Sabine, Fountzilas, George
Publicado em 2013